Pyrimidines and CNS regulation - Reply

被引：5

作者：

McLeod, HL ^{[1
]}

FernandezSalguero, P ^{[1
]}

Gonzalez, FJ ^{[1
]}

机构：

[1] NCI,MOLEC CARCINOGENESIS LAB,NIH,BETHESDA,MD 20892

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1996年 / 17卷 / 03期

关键词：

D O I：

10.1016/0165-6147(96)81584-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：107 / 107

页数：1

共 9 条

[1]

FLEMING RA, 1993, EUR J CANCER, V29A, P740

[2]

HARRIS BE, 1991, CANCER, V68, P499, DOI 10.1002/1097-0142(19910801)68:3<499::AID-CNCR2820680309>3.0.CO

[3]

2-F

[4] MULTIFOCAL INFLAMMATORY LEUKOENCEPHALOPATHY WITH 5-FLUOROURACIL AND LEVAMISOLE [J].

HOOK, CC ;

KIMMEL, DW ;

KVOLS, LK ;

SCHEITHAUER, BW ;

FORSYTH, PA ;

RUBIN, J ;

MOERTEL, CG ;

RODRIGUEZ, M .

ANNALS OF NEUROLOGY, 1992, 31 (03) :262-267

[5] HUMAN POLYMORPHISM IN DRUG-METABOLISM - MUTATION IN THE DIHYDROPYRIMIDINE DEHYDROGENASE GENE RESULTS IN EXON SKIPPING AND THYMINE URACILUREA [J].

MEINSMA, R ;

FERNANDEZSALGUERO, P ;

VANKUILENBURG, ABP ;

VANGENNIP, AH ;

GONZALEZ, FJ .

DNA AND CELL BIOLOGY, 1995, 14 (01) :1-6

[6]

THIBERVILLE L, 1994, CANCER CHEMOTH PHARM, V35, P64, DOI 10.1007/BF00686286

[7] CLINICAL AND BIOCHEMICAL FINDINGS IN 6 PATIENTS WITH PYRIMIDINE DEGRADATION DEFECTS [J].

VANGENNIP, AH ;

ABELING, NGGM ;

STROOMER, AEM ;

VANLENTHE, H ;

BAKKER, HD .

JOURNAL OF INHERITED METABOLIC DISEASE, 1994, 17 (01) :130-132

[8] NEUROTOXICITY FOLLOWING WEEKLY THERAPY WITH FOLINIC ACID AND HIGH-DOSE 5-FLUOROURACIL 24-H INFUSION IN PATIENTS WITH GASTROINTESTINAL MALIGNANCIES [J].

WEH, HJ ;

BITTNER, S ;

HOFFKNECHT, M ;

HOSSFELD, DK .

EUROPEAN JOURNAL OF CANCER, 1993, 29A (08) :1218-1219

[9] NEUROTOXICITY OF COMMONLY USED ANTINEOPLASTIC AGENTS .1. [J].

WEISS, HD ;

WALKER, MD ;

WIERNIK, PH .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (02) :75-81

← 1 →